This medication can cause liver toxicity, which your doctor may. Lenvatinib works by blocking two processes that allow cancer cells to grow. Lenvima - INN-lenvatinib Lenvima (lenvatinib) is a cancer medicine used to treat adults with differentiated thyroid carcinoma. Liver problems: LENVIMA may cause liver problems that may lead to liver failure and death.
Lenvima (Lenvatinib a Multireceptor Tyrosine Kinase Inhibitor. Lenvatinib actually targets several different changes in cancer cells and is also being researched as a treatment for liver, lung, kidney, and. Lenvatinib (Lenvima) Oncolink - Cancer Resources Jul 1 2015. A Multicenter, randomize Open-Label, Phase Trial to Compare. A Multicenter, Open-Label, Phase Trial to Compare the Efficacy.
Mg once daily lenvatinib for solid tumors in phase I studies (19.
Lenvatinib (Lenvima) Oncolink - Cancer Resources
A trial comparing lenvatinib and sorafenib for primary liver cancer.